- Company
SR Score
18,790
SR Web
18,821
Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.
Acquired by Sankyo Pharmaceuticals on September 29, 2014
Kapow helps customers drive attendance, measure success and produce bottom-line results from their event programs by combining the industry’s leading event management platform with 1,000s of experiences, partnerships, and the serv
See More
Website: https://www.ambitbio.com
Founded: January 01, 2000
Social:
